Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats.

Abstract

The purpose of these studies was to explore the use of phencyclidine (PCP)-specific high affinity antibodies as a possible treatment for phencyclidine toxicity. High affinity (Kd = 1.8 nM) anti-PCP monoclonal Fab fragments were purified from papain digested anti-PCP immunoglobulin produced in mouse ascites. Control animals (n = 5) received an i.v. bolus… (More)

Topics

  • Presentations referencing similar topics